Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irbesartan for aortic dilatation in Marfan syndrome
ISRCTN90011794Phase 3Completed
- Sponsor
- Royal Brompton and Harefield hospitals
- Start
- Sep 2010
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial in Marfan syndrome (MFS) comparing Irbesartan with Placebo (2 arms). Primary endpoint: Absolute change in aortic root diameter per year. Started Sep 2010; status: completed.
02
Drugs
irbesartan
03
Conditions
Marfan syndrome (MFS)
Beyond the preview
Go deeper on ISRCTN90011794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN90011794.